News
Eli Lilly suit against Houston’s Empower Pharmacy is a battle over access to a multi-billion dollar market for weight loss ...
Eli Lilly's Orforglipron shines in Phase III trials, potentially leading diabetes and obesity treatment by 2026. See what to ...
Novo Nordisk notified the Food and Drug Administration about several hundred units of fake semaglutide 1.0 mg in the US drug ...
You should inject Ozempic (semaglutide ... body areas. Ozempic absorbs into your body whether you inject it into your stomach, thigh, or abdomen. You should always follow the injection ...
Eli Lilly and Novo Nordisk dominate the billion-dollar weight loss drug market. Lilly has announced positive trial results ...
What a difference five years can make. Just look at Eli Lilly (NYSE: LLY). In April 2020, the drugmaker stood in the shadows ...
The U.S. Food and Drug Administration and the pharmaceutical company Novo Nordisk are urging consumers to be on the lookout ...
TIME Reveals the 2025 TIME100 List of the 100 Most Influential People in the World The issue has five worldwide covers, ...
Furthermore, Novo Nordisk should earn important label expansions for some of its current medicines while developing new ones in other areas. Semaglutide is being tested in Alzheimer's disease. And the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results